Abstract

Mef2c haploinsufficiency is implicated in behavioral deficits related to autism, schizophrenia, and intellectual disability. Although perturbations in the cerebellum, notably Purkinje cells, have been linked to these neurological disorders, the underlying mechanisms remain poorly understood. In this study, we investigated the roles of Mef2c in cerebellar Purkinje cells during the first three weeks of postnatal development. Our analysis revealed that in comparison to other members of the Mef2 family, Mef2c expression is limited to postnatal Purkinje cells. Because the role of Mef2c has not been assessed in GABAergic neurons, we set out to determine the functional significance of Mef2c by knocking down the expression of Mef2c selectively in Purkinje cells. We found that the loss of Mef2c expression during the first and second postnatal week results in an increase in dendritic arborization without impact on the general growth and migration of Purkinje cells. The influence of Mef2c on dendritic arborization persists throughout the first three weeks, but is most prominent during the first postnatal week suggesting a critical period of Mef2c activity. Additionally, the loss of Mef2c expression results in an increase in the number of spines accompanied by an increase in Gad67 and vGluT1 puncta and decrease in vGluT2 puncta. Thus, our results reveal the specific expression and functional relevance of Mef2c in developing Purkinje cells and offer insight to how disruption of the expression of Mef2c in a GABAergic neuronal subtype may lead to pathogenesis of cerebellar-associated disorders.

Highlights

  • The transcription factor myocyte enhancer factor 2c (Mef2c) has been identified in human genetic analysis as a susceptibility gene for a number of neurological disorders

  • Comparison with Gad67, a gene expressed by cerebellar GABAergic inhibitory neurons [37], shows that unlike Mef2a or Mef2d which are expressed in all three layers of the cerebellar cortex, Mef2c expression

  • We examined the role of Mef2c, a transcription factor implicated in a number of neurological disorders through characterization of the expression and functional relevance of Mef2c in the developing cerebellar cortex

Read more

Summary

Introduction

The transcription factor myocyte enhancer factor 2c (Mef2c) has been identified in human genetic analysis as a susceptibility gene for a number of neurological disorders. In addition to regulation of the development of muscle, bone, and lymphocytes [4], Mef2c orchestrates neuronal differentiation and survival as well as synapse formation in rodents [5,6,7,8,9,10,11,12]. Mef2c is expressed in many parts of the human and rodent brain [13,14,15], and activation of the transcriptional activity of Mef family members by neurotrophin and calcium influx controls a number of excitatory synapses [6, 16]. The role of Mef2c in GABAergic neurons is unknown

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call